This preclinical study demonstrates that in strontium-treated ventricular muscle, the early contraction phase is driven by intracellular cation release, while the late phase is driven by trans-sarcolemmal strontium entry.
Answers are grounded in this paper and cite their sources.
Does not inform clinical practice; leaves open the contribution of intracellular versus transsarcolemmal cation fluxes to human myocardial contraction.
Biphasic contractions were produced in dog trabeculae by replacing 90-95% of the calcium in the bathing solution with strontium. These conditions produced prolonged action potentials accompanied by contractions with two distinct phasic components. The early component disappeared slowly when the remaining Ca++ was removed, whereas the late component was eliminated quickly when Sr++ was removed. Manganese ion (0.25 mM) preferentially decreased the late component without changing the action potential, whereas caffeine and ryanodine decreased or eliminated the early component. Ryanodine did not alter the action potential. Isoproterenol rapidly increased the early component and, more slowly and to a lesser degree, increased the late component. The results suggest that the early component is caused by intracellular release of activator cation, probably from the sarcoplasmic reticulum, whereas the late component is the result of Sr++ entry across the sarcolemma, possibly by way of the slow inward current.
No takes yet. Share an insight, caveat, or question.
King et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: